Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone

Oxo substituted quinoline, isoquinoline and phthalazine derivatives are new. The oxo substituted quinoline, isoquinoline and phthalazine derivatives are compounds of formula (I) and their stereoisomers and acid addition and base salts: [Image] R 1>-CO-R 1>1>; CN; -CO-OR 1>2>; -CO-NR 1...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ANTONIUS MARINUS TERLAAK, EMMANUEL POLYMEROPOULOS, NORBERT SCHMEES, ROLAND KUEHNE, PETER DROESCHER, ULRICH BUEHMANN, PETER MUHN, HOLGER HESS-STUMPP, ECKHARD GUENTHER, PETER STREHLKE
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ANTONIUS MARINUS TERLAAK
EMMANUEL POLYMEROPOULOS
NORBERT SCHMEES
ROLAND KUEHNE
PETER DROESCHER
ULRICH BUEHMANN
PETER MUHN
HOLGER HESS-STUMPP
ECKHARD GUENTHER
PETER STREHLKE
description Oxo substituted quinoline, isoquinoline and phthalazine derivatives are new. The oxo substituted quinoline, isoquinoline and phthalazine derivatives are compounds of formula (I) and their stereoisomers and acid addition and base salts: [Image] R 1>-CO-R 1>1>; CN; -CO-OR 1>2>; -CO-NR 1>2>R 1>3>; -SO x-R 1>2>; -SO 2-NR 1>2>R 1>3>; -or A-NR 1>4>-CO-NR 1>5>R 1>6>; R 2>-CH(R 2>1>)(R 2>2>; or -CH 2CH(R 2>3>)(R 2>4>; R 3>H; halo; or 1-10C alkyl; R 4>H; or 1-10C alkyl; R 5>: R 6>-CH 2-N(R 6>1>)R 6>2>; W-X-Y : : R 1>1>and R 1>2>saturated, unsaturated, cyclic or/and (hetero)aromatic organic group; R 1>3>H; or 1-10C alkyl; A : 1-4C alkylene optionally mono-substituted with 1-6C alkyl; CO; O; or -SO x-; R 1>4>and R 1>5>H; or 1-10C alkyl; R 1>6>1-10C alkyl; 3-10C cycloalkyl; 7-20C cycloalkylalkyl; or 7-20C aralkyl, phenyl or heterocyclyl each optionally substituted with alkyl or aryl (substitution is in the ring in the case of aralkyl); x : 0-2; R 2>1>H; 1-10C alkyl; or optionally substituted phenyl; R 2>2>phenyl or naphthyl each optionally substituted; R 2>3>and R 2>4>optionally substituted phenyl; G : -C=C-; -C=N-; -N=C-; O; or S; Z : direct bond; O; S; CH-R 5>2>; CHR 5>2>-CH-R 5>3>; -CC-; or -CR 5>2>=CR 5>3>or C=R 5>2>R 5>3>each with the E or Z configuration; R 5>1>amino optionally mono-substituted with alkyl; or alkyl or 3-7C cycloalkyl each optionally substituted with halo, OH or alkoxy; L : CH 2; or NH; Q : CO; or -SO x-; R 5>2>and R 5>3>H; or alkyl; R 6>1>H; or alkyl; R 6>2>alkyl; or aralkyl or 7-20C heteroaralkyl each optionally substituted; n (not listed in above definitions) : 1 or 2. An independent claim is also included for the preparation of compounds (I). ACTIVITY : Gynecological; Cytostatic. MECHANISM OF ACTION : Gonadotrophin-releasing hormone (GnRH) antagonist.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ZA200306429B</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ZA200306429B</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ZA200306429B3</originalsourceid><addsrcrecordid>eNqNyjELwkAMhuEuDqL-h7hbKK0IHVUUV8HJpQSb9gJncl7ODv56K-gufPDywDfN3PnJop6FVsCmj58ApYXgkkOPr49bijxg4oEMcJwk7FXYkoF2kBzBSGw1RQ0seSRPaCw9OI13FZpnkw690eLbWbY8Hi77U05BG7KANxJKzXVbFkVVbNZlvav--bwBpitBkQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone</title><source>esp@cenet</source><creator>ANTONIUS MARINUS TERLAAK ; EMMANUEL POLYMEROPOULOS ; NORBERT SCHMEES ; ROLAND KUEHNE ; PETER DROESCHER ; ULRICH BUEHMANN ; PETER MUHN ; HOLGER HESS-STUMPP ; ECKHARD GUENTHER ; PETER STREHLKE</creator><creatorcontrib>ANTONIUS MARINUS TERLAAK ; EMMANUEL POLYMEROPOULOS ; NORBERT SCHMEES ; ROLAND KUEHNE ; PETER DROESCHER ; ULRICH BUEHMANN ; PETER MUHN ; HOLGER HESS-STUMPP ; ECKHARD GUENTHER ; PETER STREHLKE</creatorcontrib><description>Oxo substituted quinoline, isoquinoline and phthalazine derivatives are new. The oxo substituted quinoline, isoquinoline and phthalazine derivatives are compounds of formula (I) and their stereoisomers and acid addition and base salts: [Image] R 1&gt;-CO-R 1&gt;1&gt;; CN; -CO-OR 1&gt;2&gt;; -CO-NR 1&gt;2&gt;R 1&gt;3&gt;; -SO x-R 1&gt;2&gt;; -SO 2-NR 1&gt;2&gt;R 1&gt;3&gt;; -or A-NR 1&gt;4&gt;-CO-NR 1&gt;5&gt;R 1&gt;6&gt;; R 2&gt;-CH(R 2&gt;1&gt;)(R 2&gt;2&gt;; or -CH 2CH(R 2&gt;3&gt;)(R 2&gt;4&gt;; R 3&gt;H; halo; or 1-10C alkyl; R 4&gt;H; or 1-10C alkyl; R 5&gt;: R 6&gt;-CH 2-N(R 6&gt;1&gt;)R 6&gt;2&gt;; W-X-Y : : R 1&gt;1&gt;and R 1&gt;2&gt;saturated, unsaturated, cyclic or/and (hetero)aromatic organic group; R 1&gt;3&gt;H; or 1-10C alkyl; A : 1-4C alkylene optionally mono-substituted with 1-6C alkyl; CO; O; or -SO x-; R 1&gt;4&gt;and R 1&gt;5&gt;H; or 1-10C alkyl; R 1&gt;6&gt;1-10C alkyl; 3-10C cycloalkyl; 7-20C cycloalkylalkyl; or 7-20C aralkyl, phenyl or heterocyclyl each optionally substituted with alkyl or aryl (substitution is in the ring in the case of aralkyl); x : 0-2; R 2&gt;1&gt;H; 1-10C alkyl; or optionally substituted phenyl; R 2&gt;2&gt;phenyl or naphthyl each optionally substituted; R 2&gt;3&gt;and R 2&gt;4&gt;optionally substituted phenyl; G : -C=C-; -C=N-; -N=C-; O; or S; Z : direct bond; O; S; CH-R 5&gt;2&gt;; CHR 5&gt;2&gt;-CH-R 5&gt;3&gt;; -CC-; or -CR 5&gt;2&gt;=CR 5&gt;3&gt;or C=R 5&gt;2&gt;R 5&gt;3&gt;each with the E or Z configuration; R 5&gt;1&gt;amino optionally mono-substituted with alkyl; or alkyl or 3-7C cycloalkyl each optionally substituted with halo, OH or alkoxy; L : CH 2; or NH; Q : CO; or -SO x-; R 5&gt;2&gt;and R 5&gt;3&gt;H; or alkyl; R 6&gt;1&gt;H; or alkyl; R 6&gt;2&gt;alkyl; or aralkyl or 7-20C heteroaralkyl each optionally substituted; n (not listed in above definitions) : 1 or 2. An independent claim is also included for the preparation of compounds (I). ACTIVITY : Gynecological; Cytostatic. MECHANISM OF ACTION : Gonadotrophin-releasing hormone (GnRH) antagonist.</description><edition>7</edition><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2004</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20040211&amp;DB=EPODOC&amp;CC=ZA&amp;NR=200306429B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20040211&amp;DB=EPODOC&amp;CC=ZA&amp;NR=200306429B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ANTONIUS MARINUS TERLAAK</creatorcontrib><creatorcontrib>EMMANUEL POLYMEROPOULOS</creatorcontrib><creatorcontrib>NORBERT SCHMEES</creatorcontrib><creatorcontrib>ROLAND KUEHNE</creatorcontrib><creatorcontrib>PETER DROESCHER</creatorcontrib><creatorcontrib>ULRICH BUEHMANN</creatorcontrib><creatorcontrib>PETER MUHN</creatorcontrib><creatorcontrib>HOLGER HESS-STUMPP</creatorcontrib><creatorcontrib>ECKHARD GUENTHER</creatorcontrib><creatorcontrib>PETER STREHLKE</creatorcontrib><title>Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone</title><description>Oxo substituted quinoline, isoquinoline and phthalazine derivatives are new. The oxo substituted quinoline, isoquinoline and phthalazine derivatives are compounds of formula (I) and their stereoisomers and acid addition and base salts: [Image] R 1&gt;-CO-R 1&gt;1&gt;; CN; -CO-OR 1&gt;2&gt;; -CO-NR 1&gt;2&gt;R 1&gt;3&gt;; -SO x-R 1&gt;2&gt;; -SO 2-NR 1&gt;2&gt;R 1&gt;3&gt;; -or A-NR 1&gt;4&gt;-CO-NR 1&gt;5&gt;R 1&gt;6&gt;; R 2&gt;-CH(R 2&gt;1&gt;)(R 2&gt;2&gt;; or -CH 2CH(R 2&gt;3&gt;)(R 2&gt;4&gt;; R 3&gt;H; halo; or 1-10C alkyl; R 4&gt;H; or 1-10C alkyl; R 5&gt;: R 6&gt;-CH 2-N(R 6&gt;1&gt;)R 6&gt;2&gt;; W-X-Y : : R 1&gt;1&gt;and R 1&gt;2&gt;saturated, unsaturated, cyclic or/and (hetero)aromatic organic group; R 1&gt;3&gt;H; or 1-10C alkyl; A : 1-4C alkylene optionally mono-substituted with 1-6C alkyl; CO; O; or -SO x-; R 1&gt;4&gt;and R 1&gt;5&gt;H; or 1-10C alkyl; R 1&gt;6&gt;1-10C alkyl; 3-10C cycloalkyl; 7-20C cycloalkylalkyl; or 7-20C aralkyl, phenyl or heterocyclyl each optionally substituted with alkyl or aryl (substitution is in the ring in the case of aralkyl); x : 0-2; R 2&gt;1&gt;H; 1-10C alkyl; or optionally substituted phenyl; R 2&gt;2&gt;phenyl or naphthyl each optionally substituted; R 2&gt;3&gt;and R 2&gt;4&gt;optionally substituted phenyl; G : -C=C-; -C=N-; -N=C-; O; or S; Z : direct bond; O; S; CH-R 5&gt;2&gt;; CHR 5&gt;2&gt;-CH-R 5&gt;3&gt;; -CC-; or -CR 5&gt;2&gt;=CR 5&gt;3&gt;or C=R 5&gt;2&gt;R 5&gt;3&gt;each with the E or Z configuration; R 5&gt;1&gt;amino optionally mono-substituted with alkyl; or alkyl or 3-7C cycloalkyl each optionally substituted with halo, OH or alkoxy; L : CH 2; or NH; Q : CO; or -SO x-; R 5&gt;2&gt;and R 5&gt;3&gt;H; or alkyl; R 6&gt;1&gt;H; or alkyl; R 6&gt;2&gt;alkyl; or aralkyl or 7-20C heteroaralkyl each optionally substituted; n (not listed in above definitions) : 1 or 2. An independent claim is also included for the preparation of compounds (I). ACTIVITY : Gynecological; Cytostatic. MECHANISM OF ACTION : Gonadotrophin-releasing hormone (GnRH) antagonist.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2004</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyjELwkAMhuEuDqL-h7hbKK0IHVUUV8HJpQSb9gJncl7ODv56K-gufPDywDfN3PnJop6FVsCmj58ApYXgkkOPr49bijxg4oEMcJwk7FXYkoF2kBzBSGw1RQ0seSRPaCw9OI13FZpnkw690eLbWbY8Hi77U05BG7KANxJKzXVbFkVVbNZlvav--bwBpitBkQ</recordid><startdate>20040211</startdate><enddate>20040211</enddate><creator>ANTONIUS MARINUS TERLAAK</creator><creator>EMMANUEL POLYMEROPOULOS</creator><creator>NORBERT SCHMEES</creator><creator>ROLAND KUEHNE</creator><creator>PETER DROESCHER</creator><creator>ULRICH BUEHMANN</creator><creator>PETER MUHN</creator><creator>HOLGER HESS-STUMPP</creator><creator>ECKHARD GUENTHER</creator><creator>PETER STREHLKE</creator><scope>EVB</scope></search><sort><creationdate>20040211</creationdate><title>Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone</title><author>ANTONIUS MARINUS TERLAAK ; EMMANUEL POLYMEROPOULOS ; NORBERT SCHMEES ; ROLAND KUEHNE ; PETER DROESCHER ; ULRICH BUEHMANN ; PETER MUHN ; HOLGER HESS-STUMPP ; ECKHARD GUENTHER ; PETER STREHLKE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ZA200306429B3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2004</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ANTONIUS MARINUS TERLAAK</creatorcontrib><creatorcontrib>EMMANUEL POLYMEROPOULOS</creatorcontrib><creatorcontrib>NORBERT SCHMEES</creatorcontrib><creatorcontrib>ROLAND KUEHNE</creatorcontrib><creatorcontrib>PETER DROESCHER</creatorcontrib><creatorcontrib>ULRICH BUEHMANN</creatorcontrib><creatorcontrib>PETER MUHN</creatorcontrib><creatorcontrib>HOLGER HESS-STUMPP</creatorcontrib><creatorcontrib>ECKHARD GUENTHER</creatorcontrib><creatorcontrib>PETER STREHLKE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ANTONIUS MARINUS TERLAAK</au><au>EMMANUEL POLYMEROPOULOS</au><au>NORBERT SCHMEES</au><au>ROLAND KUEHNE</au><au>PETER DROESCHER</au><au>ULRICH BUEHMANN</au><au>PETER MUHN</au><au>HOLGER HESS-STUMPP</au><au>ECKHARD GUENTHER</au><au>PETER STREHLKE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone</title><date>2004-02-11</date><risdate>2004</risdate><abstract>Oxo substituted quinoline, isoquinoline and phthalazine derivatives are new. The oxo substituted quinoline, isoquinoline and phthalazine derivatives are compounds of formula (I) and their stereoisomers and acid addition and base salts: [Image] R 1&gt;-CO-R 1&gt;1&gt;; CN; -CO-OR 1&gt;2&gt;; -CO-NR 1&gt;2&gt;R 1&gt;3&gt;; -SO x-R 1&gt;2&gt;; -SO 2-NR 1&gt;2&gt;R 1&gt;3&gt;; -or A-NR 1&gt;4&gt;-CO-NR 1&gt;5&gt;R 1&gt;6&gt;; R 2&gt;-CH(R 2&gt;1&gt;)(R 2&gt;2&gt;; or -CH 2CH(R 2&gt;3&gt;)(R 2&gt;4&gt;; R 3&gt;H; halo; or 1-10C alkyl; R 4&gt;H; or 1-10C alkyl; R 5&gt;: R 6&gt;-CH 2-N(R 6&gt;1&gt;)R 6&gt;2&gt;; W-X-Y : : R 1&gt;1&gt;and R 1&gt;2&gt;saturated, unsaturated, cyclic or/and (hetero)aromatic organic group; R 1&gt;3&gt;H; or 1-10C alkyl; A : 1-4C alkylene optionally mono-substituted with 1-6C alkyl; CO; O; or -SO x-; R 1&gt;4&gt;and R 1&gt;5&gt;H; or 1-10C alkyl; R 1&gt;6&gt;1-10C alkyl; 3-10C cycloalkyl; 7-20C cycloalkylalkyl; or 7-20C aralkyl, phenyl or heterocyclyl each optionally substituted with alkyl or aryl (substitution is in the ring in the case of aralkyl); x : 0-2; R 2&gt;1&gt;H; 1-10C alkyl; or optionally substituted phenyl; R 2&gt;2&gt;phenyl or naphthyl each optionally substituted; R 2&gt;3&gt;and R 2&gt;4&gt;optionally substituted phenyl; G : -C=C-; -C=N-; -N=C-; O; or S; Z : direct bond; O; S; CH-R 5&gt;2&gt;; CHR 5&gt;2&gt;-CH-R 5&gt;3&gt;; -CC-; or -CR 5&gt;2&gt;=CR 5&gt;3&gt;or C=R 5&gt;2&gt;R 5&gt;3&gt;each with the E or Z configuration; R 5&gt;1&gt;amino optionally mono-substituted with alkyl; or alkyl or 3-7C cycloalkyl each optionally substituted with halo, OH or alkoxy; L : CH 2; or NH; Q : CO; or -SO x-; R 5&gt;2&gt;and R 5&gt;3&gt;H; or alkyl; R 6&gt;1&gt;H; or alkyl; R 6&gt;2&gt;alkyl; or aralkyl or 7-20C heteroaralkyl each optionally substituted; n (not listed in above definitions) : 1 or 2. An independent claim is also included for the preparation of compounds (I). ACTIVITY : Gynecological; Cytostatic. MECHANISM OF ACTION : Gonadotrophin-releasing hormone (GnRH) antagonist.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_ZA200306429B
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T21%3A05%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ANTONIUS%20MARINUS%20TERLAAK&rft.date=2004-02-11&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EZA200306429B%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true